β-D-Glucopyranosiduronic acid, 5-bromo-4-chloro-1H-indol-3-yl, compd. with cyclohexanamine (1:1) – (114162-64-0)

1141669-69-3, 2-Amino-5-Cbz-4, 5, 6, 7-tetrahydrothiazolo[5, 4-c]pyridine, 2-AMINO-5-CBZ-4, 5, 6, 7-TETRAHYDRO-1, 3-THIAZOLO[5, 4-C]PYRIDINE, Benzyl 2-amino-6, 7-dihydrothiazolo[5, 4-c]pyridine-5(4H)-carboxylate, benzyl 2-amino-6, 7-dihydro-4H-[1, 3]thiazolo[5, 4-c]pyridine-5-carboxylate, MFCD11656828, Thiazolo[5, 4-c]pyridine-5(4H)-carboxylic acid, 2-amino-6, 7-dihydro-, phenylmethyl ester, DTXSID70712320, AKOS015950503, AS-32174, SY004974, DB-019735, CS-0132946, Benzyl 2-amino-6, 7-dihydro[1, 3]thiazolo[5, 4-c]pyridine-5(4H)-carboxylate, BENZYL 2-AMINO-4H, 6H, 7H-[1, 3]THIAZOLO[5, 4-C]PYRIDINE-5-CARBOXYLATE, 2-Amino-5-Cbz-4 pound not5 pound not6 pound not7-tetrahydrothiazolo[5 pound not4-c]pyridine